Literature DB >> 11875489

A rendezvous before rejection: where do T cells meet transplant antigens?

David M Briscoe, Mohamed H Sayegh.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11875489      PMCID: PMC4471866          DOI: 10.1038/nm0302-220

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  16 in total

1.  Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.

Authors:  J Trambley; A W Bingaman; A Lin; E T Elwood; S Y Waitze; J Ha; M M Durham; M Corbascio; S R Cowan; T C Pearson; C P Larsen
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue.

Authors:  F G Lakkis; A Arakelov; B T Konieczny; Y Inoue
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

Review 3.  The role of novel T cell costimulatory pathways in autoimmunity and transplantation.

Authors:  Akira Yamada; Alan D Salama; Mohamed H Sayegh
Journal:  J Am Soc Nephrol       Date:  2002-02       Impact factor: 10.121

Review 4.  Challenges to achieving clinical transplantation tolerance.

Authors:  A D Salama; G Remuzzi; W E Harmon; M H Sayegh
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

5.  Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking.

Authors:  G J Randolph; S Beaulieu; S Lebecque; R M Steinman; W A Muller
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

Review 6.  The role of T-cell costimulatory activation pathways in transplant rejection.

Authors:  M H Sayegh; L A Turka
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

7.  Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy.

Authors:  R S Lee; K Yamada; S L Houser; K L Womer; M E Maloney; H S Rose; M H Sayegh; J C Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

8.  The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.

Authors:  H Auchincloss; R Lee; S Shea; J S Markowitz; M J Grusby; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells.

Authors:  F M Marelli-Berg; R E Hargreaves; P Carmichael; A Dorling; G Lombardi; R I Lechler
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Human endothelial cells induce and regulate cytolytic T cell differentiation.

Authors:  B C Biedermann; J S Pober
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

View more
  11 in total

1.  PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.

Authors:  Katsunori Tanaka; Monica J Albin; Xueli Yuan; Kazuhiro Yamaura; Antje Habicht; Takaya Murayama; Martin Grimm; Ana Maria Waaga; Takuya Ueno; Robert F Padera; Hideo Yagita; Miyuki Azuma; Tahiro Shin; Bruce R Blazar; David M Rothstein; Mohamed H Sayegh; Nader Najafian
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

2.  Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.

Authors:  Todd V Brennan; Qizhi Tang; Feng-Chun Liu; Vunghi Hoang; Mingying Bi; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Surg Res       Date:  2011-04-05       Impact factor: 2.192

Review 3.  The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/tolerance.

Authors:  Johannes Wedel; Hironao Nakayama; Nora M Kochupurakkal; Josephine Koch; Michael Klagsbrun; Diane R Bielenberg; David M Briscoe
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

4.  Proinflammatory functions of vascular endothelial growth factor in alloimmunity.

Authors:  Marlies E J Reinders; Masayuki Sho; Atsushi Izawa; Ping Wang; Debabrata Mukhopadhyay; Kerith E Koss; Christopher S Geehan; Andrew D Luster; Mohamed H Sayegh; David M Briscoe
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

5.  Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes.

Authors:  Miguel Ascon; Dolores B Ascon; Manchang Liu; Chris Cheadle; Chaitali Sarkar; Lorraine Racusen; Heitham T Hassoun; Hamid Rabb
Journal:  Kidney Int       Date:  2008-12-17       Impact factor: 10.612

6.  [Simultaneous pancreas-kidney transplantation. Influence of donor and recipient gender].

Authors:  M Schäffer; V Bartmann; A Wunsch; T Traska; P Schenker; S Michalski; R Viebahn
Journal:  Chirurg       Date:  2007-10       Impact factor: 0.955

Review 7.  Targeting the intragraft microenvironment and the development of chronic allograft rejection.

Authors:  Olivier Dormond; Marc Dufour; Tatsuichiro Seto; Sarah Bruneau; David M Briscoe
Journal:  Hum Immunol       Date:  2012-08-03       Impact factor: 2.850

8.  Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation.

Authors:  Martin W von Websky; Koji Kitamura; Isis Ludwig-Portugall; Christian Kurts; Maximilian von Laffert; Joel LeMaoult; Edgardo D Carosella; Kareem Abu-Elmagd; Joerg C Kalff; Nico Schäfer
Journal:  PLoS One       Date:  2016-07-12       Impact factor: 3.240

9.  Differential activation of human T cells to allogeneic endothelial cells, epithelial cells and fibroblasts in vitro.

Authors:  Dmitry Samsonov; Christopher Geehan; Craig B Woda; David M Briscoe
Journal:  Transplant Res       Date:  2012-04-24

10.  Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation.

Authors:  Sarah Bruneau; Craig Bryan Woda; Kevin Patrick Daly; Leonard Boneschansker; Namrata Gargee Jain; Nora Kochupurakkal; Alan Gabriel Contreras; Tatsuichiro Seto; David Michael Briscoe
Journal:  Front Immunol       Date:  2012-04-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.